Nevro Corp. Stock
Nevro Corp. Stock
The community is currently still undecided about Nevro Corp. with 1 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 5 € is below the current price of 5.3 € for Nevro Corp., so the potential is actually -5.66%.
Pros and Cons of Nevro Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nevro Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nevro Corp. | - | - | - | - | - | - | - |
| Atricure Inc. | - | 4.819% | 29.851% | -43.871% | -43.871% | -43.871% | -9.845% |
| Orasure Tech | -2.750% | 0.000% | 7.614% | -45.078% | -38.012% | -56.557% | -80.000% |
| SI-BONE Inc | -1.260% | -5.917% | 8.163% | 25.197% | 22.308% | - | - |
Comments
Nevro Corp. (NYSE: NVRO) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $5.85 price target on the stock, down previously from $6.00.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $4.00 price target on the stock, down previously from $9.00.
Show more
Ratings data for NVRO provided by MarketBeat
Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Piper Sandler from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for NVRO provided by MarketBeat